C26H24N6O3
Neat
468.52
211916-39-1; Methyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; Dabigatran Impurity 44; Dabigatran Impurity 16; YV8YWK9G9D; SCHEMBL6779120; NHLNCKBZUVTVHK-UHFFFAOYSA-N; CS-0165900; 1-methyl-2-[N-(4-cyanophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-methoxycarbonylethyl)-amide; 1-methyl-2-[N-(4-cyanophenyl)aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-methoxycarbonylethyl)amide; beta-Alanine, N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl- and methyl ester; methyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate? (Dabigatran Impurity pound(c); N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine methyl ester
methyl 3-[[2-[(4-cyanoanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
InChI=1S/C26H24N6O3/c1-31-22-11-8-19(26(34)32(14-12-25(33)35-2)23-5-3-4-13-28-23)15-21(22)30-24(31)17-29-20-9-6-18(16-27)7-10-20/h3-11,13,15,29H,12,14,17H2,1-2H3